CKF Tide Tables

DSIP (Delta Sleep-Inducing Peptide)

Quick Facts

PropertyValue
CategorySleep-Regulating Neuropeptide
Risk LevelModerate
AdministrationSubcutaneous Injection
Typical FrequencyNightly
Estimated Half-LifeShort Plasma Half-Life
Primary Research InterestSleep Quality / Recovery / Circadian Regulation
Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and sleep-regulating compounds. DSIP is a biologically active neuropeptide capable of influencing sleep quality, neurological signaling, and circadian-related pathways. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

  • Vial Size: 10 mg
  • Dilutant Type: BAC Water
  • Amount of Dilutant Added: 2.5 mL
  • Final Concentration: 4.00 mg/mL

At this concentration:
• 500 mcg = 0.125 mL (12.5 units)
• 1000 mcg = 0.250 mL (25.0 units)

2. Route of Administration

DSIP is most commonly administered as a subcutaneous injectable sleep-regulating peptide.

  • Primary Route: SubQ Injection
  • Preferred Timing: Approximately 30 minutes before bedtime
  • Administration Notes: Timing is often considered critical for maximizing sleep-related effects

3. Typical Research Protocols

  • Product Strength: 4.00 mg/mL
  • Typical Delivered Amount: 500–1000 mcg approximately 30 minutes before bedtime
  • Frequency: Every night, 5 days on / 2 days off
  • Cycle Length: 4–8 weeks on / 1–4 weeks off
  • Special Notes: Sleep quality responses to DSIP can vary substantially between individuals. A few doses should generally be trialed before deciding whether continued use is worthwhile. Timing is especially important. If administered too early, effects may not be noticeable. If administered too late, morning grogginess may become problematic.

4. Summary

DSIP (Delta Sleep-Inducing Peptide) is an experimental neuropeptide researched for its potential effects on sleep quality, recovery, stress regulation, and circadian rhythm support.

Research interest in DSIP commonly centers around deeper sleep quality, reduced sleep disturbances, stress resilience, and neurological recovery.

5. Mechanism of Action

DSIP is believed to influence neurological pathways involved in sleep regulation, stress response, and circadian signaling.

  • Potential enhancement of sleep quality
  • Circadian rhythm support
  • Stress modulation signaling
  • Potential reduction in sleep fragmentation
  • Neurological recovery support

The exact mechanisms of DSIP remain incompletely understood and continue to be researched.

6. Potential Benefits

  • Potential improvement in sleep quality
  • Enhanced recovery signaling
  • Reduced sleep disturbances
  • Possible stress resilience support
  • Potential improvements in next-day recovery

7. Potential Risks / Side Effects

Moderate

  • Morning grogginess
  • Vivid dreams
  • Fatigue
  • Dizziness
  • Sleep disruption if poorly timed
  • Variable effectiveness between individuals

8. Half-Life

DSIP is commonly discussed as having a relatively short plasma half-life.

However, downstream neurological and sleep-regulating effects may persist significantly longer than measurable plasma concentrations.

9. Storage Information

  • Store refrigerated before and after reconstitution
  • Protect from direct light exposure
  • Avoid repeated freeze-thaw cycles
  • Maintain sterile handling practices during preparation

10. Contraindications / Warnings

  • Use alongside strong sedatives without supervision
  • Severe sleep disorders
  • Pregnancy or breastfeeding
  • Known hypersensitivity to peptide compounds
  • Operating heavy machinery if residual sedation occurs

11. Research References

  • PubMed
  • NIH Publications
  • Sleep physiology literature
  • Peer-reviewed neurology and recovery journals